Laura Joszt


ACR Supports Continued Use of Telemedicine and Reimbursement Parity After COVID-19 Crisis

July 01, 2020

The widespread adoption of telemedicine during the coronavirus disease 2019 (COVID-19) pandemic, as well as reimbursement parity that was enacted by CMS, should be continued once the public health emergency passes, according to a new position statement by the American College of Rheumatology (ACR).

Session Highlights Barriers to Biosimilar Adoption and Lack of Provider, Payer Education

April 17, 2018

During a session at the 2018 Community Oncology Conference, hosted by the Community Oncology Alliance April 12-13 in National Harbor, Maryland, Robert M. Rifkin, MD, FACP, medical director of biosimilars at McKesson Specialty Health, The US Oncology Network, highlighted the opportunities biosimilars provide to increase access to drugs while decreasing costs, but also the remaining barriers to adoption.

New Online Consultation Tool Empowers Patients With Rheumatic Diseases, Study Finds

November 09, 2017

Chinese researchers employed a new online consultation tool to improve disease management for patients with rheumatic diseases who travel long distances for a consultation with their rheumatologist and noted significant savings for the patients.